⌘K

Home/Filings/4/0001209191-21-025861

4//SEC Filing

Harsh Michael 4

Accession 0001209191-21-025861

CIK 0001681682other

View on SEC.gov Company Profile

Filed

Apr 6, 8:00 PM ET

Accepted

Apr 7, 4:16 PM ET

Size

5.3 KB

Accession

0001209191-21-025861

Insider Transaction Report

Form 4

Period: 2021-04-05

ENDRA Life Sciences Inc.NDRA

Director

Transactions

Award
Stock Options
2021-04-05+25,000→ 25,000 total
Exercise: $2.64Exp: 2031-04-05→ Common Stock (25,000 underlying)

Footnotes (1)

[F1]This stock option grant becomes exercisable in three equal annual installments beginning April 5, 2022.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

ENDRA Life Sciences Inc.

CIK 0001681682

Entity typeother

Related Parties

1

filerCIK 0001706155

Filing Metadata

Form type: 4
Filed: Apr 6, 8:00 PM ET
Accepted: Apr 7, 4:16 PM ET
Size: 5.3 KB

View on SEC.gov